Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with ...

Dear Dr. Roach: I have read about using the immune system's response as a mechanism to battle cancer (such as brain and pancreatic) and to reduce the devastating impact that cancer and its treatment ...

Welcome to “Unsung Heroes,” my new column that asks beauty brands about their respective hero products—their bestsellers, and often a product that embodies the brand’s identity—but also dives a little ...

Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...

Last December, Sarah Eggenberger noticed a small red spot on the left side of her nose. “(It) almost presented itself like a broken capillary or an aging spot,” the 48-year-old TODAY contributor and ...

A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated ...

A form of B3 called nicotinamide cut the risk of developing repeat skin cancers by as much as 54 percent, according to new research. A large new study found that nicotinamide, a form of vitamin B3, ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new study found nicotinamide supplements may cut the ...

THIS GLOBAL MOVEMENT. YEAH, I DID, AND WHAT SHE TOLD ME AND WHAT RESEARCHERS SAY IS THAT SOME CANCERS CAN BE MISSED ON MAMMOGRAMS, ESPECIALLY FOR WOMEN WITH DENSE BREAST TISSUE. NOW, YOU SAID THE ...

Nicotinamide significantly reduces new skin cancer risk, especially when started early, with a 54% reduction after a first diagnosis. The study's findings align with previous trials, reinforcing ...

A large retrospective study of Veterans Affairs patients with a history of skin cancer has provided support to what a smaller randomized clinical trial reported about a decade ago: that patients ...

Nicotinamide reduced skin cancer risk by 14% overall in patients with a history of nonmelanoma skin cancer. The risk reduction increased to 54% when nicotinamide was started after a first skin cancer ...